Skip to main content
. Author manuscript; available in PMC: 2017 Aug 30.
Published in final edited form as: Int J Neuropsychopharmacol. 2010 Mar 3;14(2):157–174. doi: 10.1017/S1461145710000179

Table 1.

Gestational nicotine exposure modified mRNA expression of cell adhesion molecules and intracellular anchoring proteins

Cell adhesion family Gene symbol Gene name Fold change (±S.D.)
CPu NAc PFC Amy
Neurexin Nrxn1a Neurexin1 0.79±0.27 1.42±1.15 0.94±0.27 0.84±0.35
Nrxn2 Neurexin2 0.76±0.11 0.78±0.11 0.72±0.20 0.99±0.65
Nrxn3a Neurexin3 0.62±0.25 1.12±0.83 0.75±0.02* 0.84±0.23
Nlgn1 Neuroligin1 0.60±0.16* 1.25±0.84 0.84±0.08 0.86±0.21
Immunoglobulin Ncam1 Neural cell adhesion molecule 1 0.84±0.32 0.93±0.14 0.96±0.05 0.47±0.05**
Cntn4a Contactin 4 0.45±0.01*** 0.67±0.01 0.66±0.04** 1.20±0.23
Cntn5a Contactin 5 0.72±0.07* 1.20±0.96 0.82±0.67 1.06±0.79
Cntn6a Contactin 6 0.66±0.15* 1.13±0.30 0.74±0.16 1.12±0.99
Dscama Down syndrome cell adhesion molecule 0.66±0.17* 1.46±0.08 0.66±0.12* 0.95±0.43
Pecam1 Platelet/endothelial cell adhesion molecule 1 0.97±0.45 0.94±0.21 1.32±0.52 0.59±0.03*
Integrin Itgb1 Integrin beta 1 0.97±0.25 1.28±0.49 0.99±0.25 1.12±1.00
Postn Periostin, osteoblast specific factor 0.65±0.03*** 1.40±0.11* 1.58±0.42* 1.00±0.70
Vclb Vinculin 0.74±0.28 0.72±0.30 1.09±0.03 1.22±0.71
Actn1b Actinin, alpha 1 0.46±0.13* 0.69±0.27 0.95±0.18 0.93±0.40
Zyxb Zyxin 0.54±0.62 1.09±0.24 0.61±0.01 0.80±0.07
Cadherin Cdh13a Cadherin 13 0.51±0.21* 0.74±0.11 0.94±0.06 1.02±0.68
Pcdh9a Protocadherin 9 0.89±0.07 0.83±0.17 1.15±0.07 0.86±0.13
Ctnna1b Catenin (cadherin associated protein), alpha 1 0.63±0.07** 1.17±0.42 0.73±0.21 0.87±0.31
Ctnna2b Catenin (cadherin associated protein), alpha 2 0.67±0.03*** 1.22±0.16 0.85±0.13 1.10±0.92
Ctnna3b Catenin (cadherin associated protein), alpha 3 0.67±0.20 1.32±0.54 0.67±0.90 1.37±0.56
Ctnnb1b Catenin (cadherin associated protein), beta 1 0.71±0.05** 1.08±0.33 0.76±0.12 1.03±0.65
Ctnnd2ab Catenin (cadherin-associated protein), delta 2 0.61±0.09** 1.28±0.13 0.67±0.18 0.95±0.44
Vclb Vinculin 0.74±0.28 0.72±0.30 1.09±0.03 1.22±0.71
Actn1b Actinin, alpha 1 0.46±0.13* 0.69±0.27 0.95±0.18 0.93±0.40
Fynb Fyn proto-oncogene 0.62±0.10** 1.13±0.36 0.89±0.12 0.96±0.82
Adhesion GPCR Bai3a Brain-specific angiogenesis inhibitor 3 0.59±0.16* 0.74±0.27 0.96±0.11 0.94±0.32
Lphn3a Latrophilin 3 0.66±0.18* 1.08±0.56 1.06±0.17 0.62±0.02*
Others Lrrn1a Leucine rich repeat neuronal 1 0.75±0.18 1.33±0.69 1.10±0.32 0.91±0.25
Ptprda Receptor-type protein tyrosine phosphatase D 0.30±0.37 0.57±0.11* 1.69±0.82 0.79±0.14
Csmd1a CUB and Sushi multiple domains 1 0.66±0.04*** 1.13±0.33 0.54±0.05 0.96±0.03
Sgcza Sarcoglycan zeta 0.69±0.03 0.99±0.17 1.46±0.47 0.65±0.05**

CPu, Caudate putamen; NAc, nucleus accumbens; PFC, prefrontal cortex; Amy, amygdala. GPCR, G protein coupled receptor. Cell adhesion molecules and intracellular anchor proteins were modified by gestational nicotine exposure (GN). Fold change >1 indicates up-regulation of gene expression, whereas fold change <1 indicates down-regulation by GN. Data are from qRT–PCR array.

a

Genes suggested as being associated with drug addiction in human studies.

b

Genes encode intracellular proteins anchoring cell adhesion molecules.

*

p<0.05,

**

p<0.01,

***

p<0.001 significant difference between GN and control animals.